Shanghai International Group

Shanghai International Group (SIG) is a prominent state-owned financial holding and investment group based in Shanghai, China. Established in 2000, it serves as a key platform for the management of state-owned capital and the strategic development of Shanghai's core industries, with a significant focus on the life sciences and healthcare sectors. While not a drug development company itself, SIG is a primary driver of the biotechnology ecosystem through its management of large-scale industrial funds, such as the Shanghai Biomedical Fund and the Shanghai Sci-Tech Innovation Center Capital. The group holds substantial stakes in leading financial institutions and pharmaceutical giants like Shanghai Pharmaceuticals, playing a pivotal role in funding and scaling innovative healthcare companies in the Yangtze River Delta region.